Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study
Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in 'off' period rescue. According to our results, apomorphine proved faster in reverting '...
Guardado en:
| Publicado: |
1997
|
|---|---|
| Materias: | |
| Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03625664_v20_n2_p165_Merello http://hdl.handle.net/20.500.12110/paper_03625664_v20_n2_p165_Merello |
| Aporte de: |
| id |
paper:paper_03625664_v20_n2_p165_Merello |
|---|---|
| record_format |
dspace |
| spelling |
paper:paper_03625664_v20_n2_p165_Merello2023-06-08T15:35:25Z Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study 'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in 'off' period rescue. According to our results, apomorphine proved faster in reverting 'off' periods and should still be regarded as the drug of choice for this treatment modality. 1997 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03625664_v20_n2_p165_Merello http://hdl.handle.net/20.500.12110/paper_03625664_v20_n2_p165_Merello |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| topic |
'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration |
| spellingShingle |
'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
| topic_facet |
'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration |
| description |
Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in 'off' period rescue. According to our results, apomorphine proved faster in reverting 'off' periods and should still be regarded as the drug of choice for this treatment modality. |
| title |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
| title_short |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
| title_full |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
| title_fullStr |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
| title_full_unstemmed |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
| title_sort |
comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: a double-blind single-dose study |
| publishDate |
1997 |
| url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03625664_v20_n2_p165_Merello http://hdl.handle.net/20.500.12110/paper_03625664_v20_n2_p165_Merello |
| _version_ |
1768543183062433792 |